Cargando…
Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274573/ https://www.ncbi.nlm.nih.gov/pubmed/37332347 http://dx.doi.org/10.3389/fphar.2023.1225522 |
| _version_ | 1785059763826982912 |
|---|---|
| author | Grohs, Laura Cheng, Linhan Cönen, Saskia Haddad, Bassam G. Bülow, Astrid Toklucu, Idil Ernst, Lisa Körner, Jannis Schmalzing, Günther Lampert, Angelika Machtens, Jan-Philipp Hausmann, Ralf |
| author_facet | Grohs, Laura Cheng, Linhan Cönen, Saskia Haddad, Bassam G. Bülow, Astrid Toklucu, Idil Ernst, Lisa Körner, Jannis Schmalzing, Günther Lampert, Angelika Machtens, Jan-Philipp Hausmann, Ralf |
| author_sort | Grohs, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10274573 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102745732023-06-17 Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor Grohs, Laura Cheng, Linhan Cönen, Saskia Haddad, Bassam G. Bülow, Astrid Toklucu, Idil Ernst, Lisa Körner, Jannis Schmalzing, Günther Lampert, Angelika Machtens, Jan-Philipp Hausmann, Ralf Front Pharmacol Pharmacology Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10274573/ /pubmed/37332347 http://dx.doi.org/10.3389/fphar.2023.1225522 Text en Copyright © 2023 Grohs, Cheng, Cönen, Haddad, Bülow, Toklucu, Ernst, Körner, Schmalzing, Lampert, Machtens and Hausmann. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Grohs, Laura Cheng, Linhan Cönen, Saskia Haddad, Bassam G. Bülow, Astrid Toklucu, Idil Ernst, Lisa Körner, Jannis Schmalzing, Günther Lampert, Angelika Machtens, Jan-Philipp Hausmann, Ralf Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_full | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_fullStr | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_full_unstemmed | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_short | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_sort | corrigendum: diclofenac and other non-steroidal anti-inflammatory drugs (nsaids) are competitive antagonists of the human p2x3 receptor |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274573/ https://www.ncbi.nlm.nih.gov/pubmed/37332347 http://dx.doi.org/10.3389/fphar.2023.1225522 |
| work_keys_str_mv | AT grohslaura corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT chenglinhan corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT conensaskia corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT haddadbassamg corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT bulowastrid corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT toklucuidil corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT ernstlisa corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT kornerjannis corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT schmalzinggunther corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT lampertangelika corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT machtensjanphilipp corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT hausmannralf corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor |